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DimerizationMembrane protein interactions, which underlie biological function, take place in the complex cellular mem-
brane environment. Plasma membrane derived vesicles are a model system which allows the interactions
between membrane proteins to be studied without the need for their extraction, puriﬁcation, and reconsti-
tution into lipid bilayers. Plasma membrane vesicles can be produced from different cell lines and by different
methods, providing a rich variety of native-like model systems. With these choices, however, questions arise
as to how the different types of vesicle preparations affect the interactions between membrane proteins. Here
we address this question using the glycophorin A transmembrane domain (GpA) as a model system. We
compare the dimerization of GpA in six different vesicle preparations derived from Chinese hamster ovary
(CHO), Human Embryonic Kidney 293T (HEK 293T) and A431 cells. We accomplish this with the use of a
FRET-based method which yields the FRET efﬁciency, the donor concentration, and the acceptor concentra-
tion in each vesicle. We show that the vesicle preparation protocol has no statistically signiﬁcant effect on
GpA dimerization. Based on these results, we propose that any of the six plasma membrane preparations in-
vestigated here can be used as a model system for studies of membrane protein interactions.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Membrane proteins (MPs) fold in a complex heterogeneous envi-
ronment [1,2]. A useful paradigm for membrane protein folding is the
two-stage model which assumes that folding occurs via (i) insertion
of the hydrophobic transmembrane (TM) helices in membranes,
followed by (ii) lateral association of the inserted helices into func-
tional membrane proteins [3]. There have been numerous studies of
TM helix lateral interactions, which have contributed signiﬁcantly to-
ward the understanding of membrane protein folding [4–8]. Such TM
helix dimerization studies have been performed in a variety of hydro-
phobic environments including detergents, bicelles, lipid bilayers,
and bacterial membranes [9–14]. In our lab, we have performed mea-
surements in mammalian membranes using a FRET-based technique
called Quantitative Imaging FRET (QI-FRET) [15,16]. In these experi-
ments, cells are transfected with genes encoding for TM helices
tagged with ﬂuorescent proteins. After the proteins are trafﬁcked to
the plasma membrane, the cells are incubating in a vesiculation buff-
er. As a result, the cells shed vesicles as part of their apoptotic re-
sponse to the vesiculation buffer stress [17–19]. The membranes of
these vesicles contain various membrane proteins and mimic the nat-
ural crowded membrane environment. We have demonstrated that
these vesicles can serve as a plasma membrane model to study therights reserved.thermodynamics of TM helix dimerization, as the distribution of the
proteins in the vesicles is homogeneous and the data are well de-
scribed by models assuming monomer–dimer equilibrium in the
membrane [15,16].
The most widely used vesiculation protocol uses DTT and formal-
dehyde [17]. An alternative osmotic vesiculation buffer has been de-
scribed in the literature by Cohen and co-workers, but it works only
for A431 cells [20]. We have recently developed a new vesiculation
buffer, containing chloride salts, which can be used for both A431
and CHO cells [21]. Thus, plasma membrane derived vesicles can
now be produced from different cell lines and with different methods,
providing a variety of native-like model systems. Questions therefore
arise (1) whether MP interactions differ in different preparations of
plasma derived vesicles and (2) whether a particular vesicle prepara-
tion should be preferred over others for studies of MP interactions.
Many of the principles behind TM helix dimerization have emerged
from studies of the TM domain of the erythrocyte glycoprotein
glycophorin A (GpA) [9,10]. Interestingly, GpA dimerization has been
shown to be very sensitive to the lipid composition. Effects as large as
9 kcal/mol were measured upon the addition of charged lipids, non-
bilayer lipids, or bacterial membrane proteins [13]. In this study we
asked whether the cell line used to produce plasmamembrane derived
vesicles, or the particular method of vesiculation, affects the dimeriza-
tion of GpA. To answer this question, we measured and compared the
dimerization of GpA in six different vesicle preparations derived from
CHO, HEK 293T and A431 cells.
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2.1. Plasmid constructs
The GpA plasmid was created as described previously [15]. The
eYFP plasmid was a kind gift from Dr. M. Betenbaugh (Johns Hopkins
University, Baltimore, MD) and the pRSET B-mCherry plasmid was a
gift from Dr. R. Tsien (University of California, San Diego). All of the
plasmids used for mammalian expression were constructed with
the pcDNA 3.1(+) vector (Invitrogen). All primers were purchased
from Invitrogen.
The cloning procedure used to create the plasmids pcDNA–GpA–eYFP
and pcDNA–GpA–mCherry is published [15]. The plasmids encoded for a
N-terminal signal peptide directing GpA to the plasma membrane, the
GpA TM domain (sequence: LIIFGVMAGVIGTILLISYGIRRL), a ﬂexible 15
amino acid-long (GGS)5 linker, and a ﬂuorescent protein (either eYFP
and mCherry). The bacterial expression and puriﬁcation of the soluble
eYFP andmCherry used for calibration of concentrations was performed
as described in [22].2.2. Cell growth and transfection
Chinese Hamster Ovary (CHO), Human Embryonic Kidney 293T
(HEK 293T) and A431 cells were stored in liquid nitrogen and thawed
when needed. The cells were cultured and grown to conﬂuency, and
passed ﬁve times prior to experimentation. After 35 passages, the
cells were discarded.
Cells were grown at 37 °C with 5% CO2. 4 × 105 cells were seeded
perwell in a 6-well plate 24 h before transfection. Transfectionwas car-
ried out using Fugene HD (Promega.Corporation), following the
manufacturer's protocol. Cells were co-transfected with pcDNA–GpA–
eYFP and pcDNA–GpA–mCherry, and vesiculated 24 h post transfec-
tion. HEK293T and CHO cells were transfected with a total of 3 μg of
the plasmid DNA constructs while A431 cells were transfected with a
total of 6 μg of DNA.2.3. Vesiculation
Vesiculationwas performed using three differentmethods [17,20,21].
To vesiculate with the DTT/formaldehyde method developed by Scott
[17–19], 70% conﬂuent HEK293T, CHO and A431 cells were rinsed with
PBS (pH 7.4) containing 0.75 mM calcium chloride and 0.5 mM magne-
sium chloride (CM-PBS), and incubatedwith 1 mL of a vesiculation buffer
containing 25 mM formaldehyde, 0.5 mM 1,4-dithiotreitol (DTT) and
protease inhibitor cocktail (Roche Applied Science) at 37 °C. To quench
the formaldehyde after vesiculation, glycine solution in PBS was added
to the vesiculationbuffer to aﬁnal concentration of 0.125 M.A largenum-
ber of vesicles were produced after 2 h, and the vesicles were transferred
into 4-well Nunc Lab-Tek II chambered coverslips for imaging.
To vesiculate with the salt cocktail osmotic stress method of Cohen
et al. [20], 70% conﬂuent A431 cells were rinsed once with PBS (pH
7.4), and incubated with 1 mL of 10% PBS buffer at room temperature
for 10 min. Subsequently the cells were incubated with 1 mL of hyper-
tonic buffer containing 100 mM NaCl, 50 mM Na2HPO4, 0.5 mM KCl,
0.5 mM MgSO4 and protease inhibitor cocktail adjusted to pH of 8.5.
Vesicles were produced after 2 h and imaged in 4-well chambered
coverslips.
To vesiculate using the chloride salt osmotic stress method that
we recently developed [21], 70% conﬂuent CHO and A431 cells were
rinsed three times with 30% PBS buffer at room temperature. The
cells were then incubated with 1 mL of hypertonic buffer containing
200 mM NaCl, 5 mM KCl, 0.5 mM MgSO4, 0.75 mM CaCl2, 100 mM
bicine and protease inhibitor cocktail adjusted to pH of 8.5. Vesicles
were collected after 12 h for imaging.2.4. FRET measurements of dimerization propensities
Vesicles were imaged using a Nikon Eclipse confocal laser scanning
microscope using a 60× water immersion objective. All the images
were collected and stored at a 512 × 512 resolution. Three distinct
scans were performed for each vesicle: (1) excitation at 488 nm, with
a 500–530 nm emission ﬁlter (donor scan); (2) excitation at 488 nm,
with a 565–615 nm emission ﬁlter (FRET scan); and (3) excitation at
543 nm,with a 650 nm longpass ﬁlter (acceptor scan) as discussed pre-
viously [16,22].
The three images for each vesicle were analyzed using a Matlab®
program to obtain the ﬂuorescence intensity across the vesicle mem-
brane [16,22,23]. The ﬂuorescence intensity across the membrane
was modeled with a Gaussian function and the background intensity
with as an error function. The integration of the Gaussians from the
donor, acceptor, and FRET scans yielded the three ﬂuorescence inten-
sities, IA, ID, and IFRET, for each vesicle. These three intensities were
then used to calculate the donor and acceptor concentration in the
vesicle as described in detail elsewhere [15].
Brieﬂy, the concentration of the donor-labeled GpA per unit area
in each vesicle was calculated according to:
CD ¼
ID þ GF IFRET−βDID−βAIAð Þ
iD
ð1Þ
and the concentration of the acceptor-labeled GpA per unit area was
determined as:
CA ¼
IA
iA
: ð2Þ
The coefﬁcients iD and iA in Eqs. (1) and (2) are calibration constants
for the donor and the acceptor, respectively, andβD andβA are the donor
and acceptor bleed-through coefﬁcients. These parameters were deter-
mined by analyzing puriﬁed protein solutions of known concentrations
[22]. GF is the gauge factor, a parameter which relates the sensitized
emission of the acceptor to the quenching of the donor. It was calculated
by analyzing vesicles loaded with a linked eYFP–mCherry soluble pro-
tein as described elsewhere [22].
The FRET efﬁciency for each vesicle is determined as:
E ¼ 1− ID
ID þ GF IFRET−βDID−βAIAð Þ
ð3Þ
This FRET efﬁciency was then corrected for a FRET contribution
which arises due to random proximity (within distances of 100 Å)
of donor and acceptors. The proximity correction is based on a
model by Wolber and Hudson [24] that has been experimentally ver-
iﬁed [25]. This correction yielded FRET due to sequence-speciﬁc di-
merization, ED. The dimeric fraction (i.e. the fraction of proteins that
are dimeric) in each vesicle was then calculated as [26,27]:
f ¼ ED
xAE
: ð4Þ
Here xA is the fraction of proteins labeled with the acceptor
ﬂuorophore, and E is the FRET efﬁciency in a dimer containing a
donor and an acceptor. The value of E in Eq. (4) is known for the GpA
construct used here, E = 0.63 ± 0.04, corresponding to a 48.5 Å sepa-
ration distance between the ﬂuorophores in the dimer [15].
The lateral dimerization of GpA in the membrane is described by
the following reaction scheme:
M þM↔KD D; ð5Þ
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Fig. 1. FRET efﬁciencies measured for GpA in plasma membrane derived vesicles, as a
function of acceptor concentration. Genes encoding GpA attached to either YFP or
mCherry at its C-terminus via a (GGS)5 linker were expressed in cells. After GpA was traf-
ﬁcked to the plasmamembrane, the cells were vesiculated using three different methods.
(A) CHO, HEK293T and A431 vesicles, produced with the DTT/formaldehyde method of
Scott [17]. (B) CHO vesicles, produced with the DTT/formaldehyde method and the new
chloride salt osmotic method that we have developed [21]. (C) A431 cells vesiculated
using theDTT/formaldehydemethod, the chloride saltmethod, and the salt cocktailmeth-
od developed by Cohen et al. [20]. Each data point corresponds to a single vesicle.
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KD ¼ D½ = M½ 2; ð6Þ
and the total protein concentration is given by:
T½  ¼ M½  þ 2 D½ : ð7Þ
KD is determined by ﬁtting the dimerization model given by
Eqs. (5) through (7) to the measured dimeric fractions (given by
Eq. (4)). Deﬁning the standard state as Kst = 1 nm2/protein, the
free energy of dimer formation is calculated according to:
ΔG ¼−RT ln KD
Kst
 
ð8Þ
2.5. Statistical analysis
The errors in the calculated dimerization free energies were deter-
mined using Matlab, by (i) calculating the conﬁdence interval for KD
when ﬁtting the model to all the experimental dimeric fractions prior
to binning and (ii) taking into account the experimental uncertainties
in the ﬂuorescence calibration parameters. The free energies calculated
for all membrane preparations were compared using ANOVA. The pa-
rameters inputted into the ANOVA calculation were the free energies,
the standard errors, and the number of data points (number of vesicles
analyzed) which exceeded 200 in each case.
3. Results
Here we worked with six different plasma membrane vesicle
preparations. Three of them utilized the DTT/formaldehyde vesicula-
tion method and were produced from CHO, HEK293T, and A431
cells. The ﬁrst cell line, CHO, is derived from the ovaries of Chinese
Hamster and is perhaps the most widely used mammalian cell line
for recombinant protein expression, as CHO cells grow fast and pro-
duce large protein quantities. The second cell line, HEK 293T, is a
human cell line of kidney epithelial origin that is used for the tran-
sient and stable expression of human proteins. The third cell line,
A431, is an epidermoid carcinoma cell line that is highly sensitive to
mitogenic stimuli, and is usually avoided in studies of recombinant
proteins. It was used here because this is the only cell line that can
be vesiculated with the osmotic buffer of Cohen et al. [20]. Notewor-
thy, A431 cells express very high levels (3 × 106 copies per cell) of
the Epidermal Growth Factor Receptor (EGFR). This is a receptor
which functions via lateral dimerization in the plasma membrane,
and the homodimerization of its TM domains is believed to occurs
through the GxxxG motif [28,29], the very same sequence motif that
drives GpA dimerization. Thus this cell line gave us the opportunity
to access the likelihood of any “promiscuous” interactions between
GpA and EGFR.
A431 cells were vesiculated using the three vesiculationmethods de-
scribed in Materials and methods, while CHO cells were vesiculated
using the DTT/formaldehyde and the chloride salt method. HEK 293T
cells, on the other hand, could be vesiculatedwith theDTT/formaldehyde
method only, as the cells quickly detached in the other two vesiculation
buffers and thus the vesicles could not be isolated for imaging.
We measured the energetics of Glycophorin A TM domain dimer-
ization in plasma membrane vesicles in the six different vesicle prep-
arations discussed above. Cells were co-transfected with 3–6 μg DNA
encoding GpA–TM–eYFP and GpA–TM–mCherry. After GpA expres-
sion and its trafﬁcking to the plasma membranes of the cells, the
cells were vesiculated as described in Materials and methods. After
vesicle production, single vesicles were imaged in a laser-scanning
confocal ﬂuorescence microscope such that three different images,donor, FRET, and acceptor images were captured for each vesicle as
described [20]. The donor concentration, the acceptor concentration,
and the FRET efﬁciencies in each vesicle were determined using
Eqs. (1), (2), and (3) as outlined in Materials and methods.
The measured FRET efﬁciencies are shown in Fig. 1 as a function of
the acceptor concentration. Each data point in Fig. 1 corresponds to a
single vesicle. Fig. 1A compares the FRET efﬁciencies measured in ves-
icles derived from CHO, HEK 293T, and A431 cells upon incubation
with the DTT/formaldehyde buffer. Fig. 1B shows the FRET efﬁciencies
in CHO cells vesiculated with the DTT/formaldehyde and the chloride
salt osmotic stress buffer. Fig. 1C compares the FRET efﬁciencies mea-
sured in A431 vesicles, produced with the three vesiculation buffers.
These data are replotted in Supplemental Information.
The calculation of dimeric fractions (i.e. the fraction of proteins
that are dimeric) in each vesicle has been discussed in detail in sev-
eral of our publications [16,22,23]. The calculations follow the proto-
col that was originally developed to determine dimerization free
energies in lipid vesicles [27,30]. Brieﬂy, the dimeric fraction was
calculated for each vesicle using Eq. (4). Then, the calculated dimeric
fractions were averaged within bins of total protein concentration of
width = 5 × 10−4 molecules/nm2. The averaged dimeric fractions as a
function of total concentration, along with the standard errors, are
shown in Fig. 2A, B and C (and replotted in Supplemental Information).
Table 1
Dimerization constants and dimerization free energies measured for GpA in plasma
membrane derived vesicles. By ANOVA, there are no signiﬁcant differences between
the measured free energies in the complete data set, and there are no signiﬁcant
pairwise differences, either.
Cell line Vesiculation method K (nm2/protein) ΔG (kcal/mol)
CHO DTT/formaldehyde 312 −3.4 ± 0.2
CHO chloride salt 526 −3.7 ± 0.2
HEK293T DTT/formaldehyde 312 −3.4 ± 0.2
A431 DTT/formaldehyde 204 −3.2 ± 0.2
A431 salt cocktail 769 −4.0 ± 0.2
A431 chloride salt 625 −3.8 ± 0.3
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the experimental dimeric fractions and calculate the dimerization con-
stants. The predicted dimeric fractions were calculated as a function of
the total concentration [T], based on the dimerization model given by
Eqs. (5) to (7), for any value of the dimerization constant KD. Then,
the value of KDwas optimized using aMatlab code such that the predic-
tion gave the bestﬁt to the single-vesicle dimeric fractions (prior to bin-
ning). The ﬁts are shown in Fig. 2 with the solid lines, allowing a direct
comparison between the binned data and theﬁts. The optimal KD values
and the corresponding dimerization free energies (calculated using
Eq. (8)) are shown in Table 1. We see that the cell type and the vesicu-
lation method have a very modest effect on GpA dimerization, not ex-
ceeding ~0.8 kcal/mol.
The six different free energies were compared using ANOVA as de-
scribed in Materials and methods. The ANOVA analysis showed that
there were no signiﬁcant differences between the measured free ener-
gies overall, and there were no signiﬁcant pairwise differences, either.
In addition, the ANOVA analysis of the separate data sets shown in
Fig. 2A, B, and C, shows no statistical signiﬁcant differences, either. As
GpA dimerization strength in A431 vesicles is similar to the strength in
CHO and HEK vesicles, there is no evidence of promiscuous interactions
between GpA and EGFR due to the presence of GxxxG motifs in both
proteins. If a previously reported value for GpA dimerization in CHOves-
icles produced via the formaldehyde/DTTmethod,−3.9 ± 0.2 kcal/mol
[15], is included with the current data set, the ANOVA analysis of all of1E-4 1E-3 0.01 0.1
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Fig. 2. Dimeric GpA fractions as a function of total GpA concentration. The dimeric frac-
tions were averaged in bins of 5 × 10−4 receptors/nm2. The solid lines are the ﬁts of
the dimerization model to the data points prior to their binning. (A) CHO, HEK293T
and A431 vesicles, produced with the DTT/formaldehyde method. (B) CHO vesicles,
produced with the DTT/formaldehyde method and the chloride salt osmotic method.
(C) A431 cells vesiculated using the three different methods.the free energy measurements shows no signiﬁcant difference between
this past measurement and the new data set.
4. Discussion
Plasmamembrane derived vesicles give us the opportunity to study
the interactions between complexmembrane proteins. As the genes are
introduced into mammalian cells, the recombinant membrane proteins
are synthesized and folded correctly, and then glycosylated and traf-
ﬁcked to the plasmamembrane. Thus, the interaction strength between
native glycosylated MPs can be quantiﬁed in a native-like membrane
without the need for their extraction, puriﬁcation, and reconstitution.
The lack of control over the composition of the vesicles, however, is a
shortcoming of this technique. Also, we do not yet completely under-
stand the apoptotic processes which are triggered by the buffer stress
and result in vesiculation. The plasma membrane derived vesicles lack
a transmembrane potential and a cytoskeleton, and are not a perfect
mimic of the plasma membrane. Yet, plasma membrane derived vesi-
cles are the onlymodel system that has allowed us thus far to character-
ize the interaction strength between glycosylated membrane proteins
in quantitative terms [16,23].
To learn more about the utility and the limitations of the plasma
membrane derived vesicles, here we characterized the interactions of
GpA in the six different vesicle preparations. The goal of the study was
to learn whether GpA interactions differ in different plasma derived
vesicles, and whether a particular vesicle preparation should be pre-
ferred over others.Wemeasured similarGpAdimerization free energies
in all vesicle preparations (Table 1). Indeed, the ANOVA analysis shows
that the observed differences are not statistically signiﬁcant. Thus, the
different preparation methods yielded equivalent membrane model
systems for studies of GpA interactions. Considering GpA as a general
membrane proteinmodel, our results suggest that any of the six vesicle
preparations can be used to produce a relevant data set for amembrane
protein of interest.
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